IN BRIEF: Kingsley Capital reduces stake in Oxford Cannabinoid

Oxford Cannabinoid Technologies Holdings PLC - Oxford-based pharmaceutical company developing ...

Alliance News 20 October, 2023 | 8:37AM
Email Form Facebook Twitter LinkedIn RSS

Oxford Cannabinoid Technologies Holdings PLC - Oxford-based pharmaceutical company developing prescription cannabinoid medicine - Kingsley Capital Partners LLP sells 54.9 million shares in the company, of which 20.5 million were acquired by Neil Mahapatra in his own name. Neil Mahapatra, the managing partner of KCP, controls the exercise of 100% of KCP's voting rights in OCT. Kingsley Capital Partners stake in Oxford Cannabinoid falls to 14.95% from 20.76%.

Current stock price: 0.74 pence, down 1.7% in London on Friday morning

12-month change: up 29%

By Holly Beveridge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Oxford Cannabinoid Technologies Holdings PLC

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures